Nanotechnology Drug Delivery

Nanotechnology Drug Delivery Market (By Technology - Nanocrystals, Nanoparticles, Liposomes, Micelles, Nanotubes, and Others; By Application - Neurology, Oncology, Cardiovascular/Physiology, Anti-inflammatory/Immunology, Anti-infective, and Others) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2015 - 2023

  • Rep Id : TMRGL1822
  • Published On : Mar 2016
  • No. of Pages : 120
  • Category : Pharmaceutical


Chapter 1 Introduction
1.1 Report Description
1.2 Research Methodology
1.3 Market Segmentation

Chapter 2 Executive Summary
2.1 Market Snapshot: Global Nanotechnology Drug Delivery Market 
2.2 Nanotechnology based Drug Delivery (Historical Development)
2.3 Industrial Prospective
2.4 Global Nanotechnology Drug Delivery Market Share, by Geography, 2014 & 2023 (Value %)
2.5 Global Nanotechnology Drug Delivery Market Share, by Technology, 2014 (Value %)
2.6 Global Nanotechnology Drug Delivery Market Share, by Application, 2014 (Value %)

Chapter 3 Market Overview
3.1 Introduction
     3.1.1 Market Definition
            3.1.1.1 Industry Overview
            3.1.1.2 Global Nanotechnology Drug Delivery Market  Share
            3.1.1.3 Technology Trends
     3.1.2 Industry Challenges
     3.1.3 Sales Data for Some Marketed Nano-Pharmaceuticals
     3.1.4 Investigational Nano-Pharmaceuticals
     3.1.5 Patent Landscape
3.2 Market Dynamics
3.3 Porter’s Five Forces Analysis
3.4 Market Attractiveness Analysis - Global Nanotechnology Drug Delivery Market
3.5 Global Nanotechnology Drug Delivery Market, by Key Players, 2014 (%)

Chapter 4 Nanotechnology Drug Delivery Market, by Technology
4.1 Introduction
     4.1.1 Nanotechnology Drug Delivery Market Revenue, by Technology, 2013–2023 (US$ Mn)
4.2 Nanocrystals
     4.2.1 Global Nanocrystals Market Revenue, 2013–2023 (US$ Mn)
4.3 Nanoparticles
     4.3.1 Global Nanoparticles Market Revenue, 2013–2023 (US$ Mn)
            4.3.2.1 Dendrimers
            4.3.2.1 Global Dendrimers Market Revenue, 2013–2023 (US$ Mn)
     4.3.3 Gold Nanopartilces
            4.3.3.1 Global Gold Nanoparticles Market Revenue, 2013–2023 (US$ Mn)
     4.3.4 Fullerens
            4.3.4.1 Global Fullerens Market Revenue, 2013–2023 (US$ Mn)
     4.3.5 Other Nanoparticle Market Revenue, 2013-2023 (US$ Mn)
4.4 Liposomes
     4.4.1 Global Liposomes Market Revenue, 2013–2023 (US$ Mn)
4.5 Micelles
     4.5.1 Global Micelles Market Revenue, 2013–2023 (US$ Mn)
4.6 Nanotubes 
     4.6.1 Global Nanotubes Market Revenue, 2013–2023 (US$ Mn)
4.7 Others
     4.7.1 Global Others Market Revenue, 2013–2023 (US$ Mn)

Chapter 5 Applications
5.1 Introduction
     5.1.1 Global Nanotechnology Drug Delivery Market Revenue, by Application, 2013–2023 (US$ Mn)
5.2 Neurology
     5.2.1 Global Neurology Market Revenue, 2013–2023 (US$ Mn)
5.3 Oncology
     5.3.1 Global Oncology Market Revenue, 2013–2023 (US$ Mn)
5.4 Cardiovascular/Physiology
     5.4.1 Global Cardiovascular Market Revenue, 2013–2023 (US$ Mn)
5.5 Anti-inflammatory/Immunology
     5.5.1 Global Anti-inflammatory Market Revenue, 2013–2023 (US$ Mn)
5.6 Anti-infective
     5.6.1 Global Anti-infective Market Revenue, 2013–2023 (US$ Mn)
5.7 Other Applications
     5.7.1 Global Other Applications Market Revenue, 2013–2023 (US$ Mn)

Chapter 6 Geography
6.1 Introduction
     6.1.1 Global Nanotechnology Drug delivery Market Revenue, by Geography, 2013–2023 (US$ Mn)
6.2 North America
     6.2.1 North America Nanotechnology Drug delivery Market Revenue, by Country, 2013–2023 (US$ Mn)
6.3 Europe
     6.3.1 Europe Nanotechnology Drug Delivery Market Revenue, by Country, 2013–2023 (US$ Mn)
6.4 Asia Pacific
     6.4.1 Asia Pacific Nanotechnology Drug Delivery Market Revenue, by Country, 2013–2023 (US$ Mn)
6.5 Latin America
     6.5.1 Latin America Nanotechnology Drug Delivery Market Revenue, by Country, 2013–2023 (US$ Mn)
6.7 Rest of the World
     6.7.1 Rest of the World Nanotechnology Drug Delivery Market Revenue, 2013–2023 (US$ Mn)

Chapter 7 Company Profiles
7.1 AbbVie, Inc.
7.2 Amgen Inc.
7.3 Celgene Corporation 
7.4 Johnson & Johnson 
7.5 Merck & Co., Inc.
7.6 Novartis International AG
7.7 Perrigo Company plc
7.8 Pfizer, Inc.
7.9 Teva Pharmaceutical Industries Ltd.

List of Tables

TABLE 1 Market Snapshot: Global Nanotechnology Drug Delivery Market
TABLE 2 Sales Data for some Marketed Nano Pharmaceuticals
TABLE 3 Investigational Nano Pharmaceuticals
TABLE 4 Patent Landscape
TABLE 5 Global Nanotechnology Drug Delivery Market Revenue, by Technology, 2013 – 2023 (US$ Mn)
TABLE 6 Global Nanoparticle Market Revenue, by Types, 2013 – 2023 (US$ Mn)
TABLE 7 Global Nanotechnology Drug Delivery Market Revenue, by Application, 2013 – 2023 (US$ Mn)
TABLE 8 Global Nanotechnology Drug Delivery Market Revenue, by Geography, 2013 – 2023 (US$ Mn)
TABLE 9 North America Nanotechnology Drug Delivery Market Revenue, by Country, 2013 – 2023 (US$ Mn)
TABLE 10 Europe Nanotechnology Drug Delivery Market Revenue, by Country, 2013 – 2023 (US$ Mn)
TABLE 11 Asia Pacific Nanotechnology Drug Delivery Market Revenue, by Country, 2013 – 2023 (US$ Mn)
TABLE 12 Latin America Nanotechnology Drug Delivery Market Revenue, by Country, 2013 – 2023 (US$ Mn)

List of Figures

FIGURE 1 Market Segmentation: Nanotechnology Drug Delivery Market
FIGURE 2 Global Nanotechnology Drug Delivery Market Share, by Geography 2014 and 2023 (Value %)
FIGURE 3 Global Nanotechnology Drug Delivery Market, by Technology, 2014
FIGURE 4 Global Nanotechnology Drug Delivery Market, by Application, 2014
FIGURE 5 Patent Filing for Nanoparticles, 2000 – 2014
FIGURE 6 Patent Filing for Major Nanotechnology Drug Delivery Platforms, 2000 – 2014
FIGURE 7 Porters Five Forces Analysis: Global Nanotechnology Drug Delivery Market
FIGURE 8 Global Nanotechnology Drug Delivery Market, by Geography, 2014
FIGURE 9 Global Nanotechnology Drug Delivery Market Share, by Key Players, 2013 (%)
FIGURE 10 Global Nanotechnology Drug Delivery Market Share, by Key Players, 2014 (%)
FIGURE 11 Global Nanocrystals Technology Market Revenue, 2013 – 2023 (US$ Mn)
FIGURE 12 Global Dendrimers Technology Market Revenue, 2013 – 2023 (US$ Mn)
FIGURE 13 Global Gold Nanoparticles Technology Market Revenue, 2013 – 2023 (US$ Mn)
FIGURE 14 Global Fullerenes Technology Market Revenue, 2013 – 2023 (US$ Mn)
FIGURE 15 Global Other Nanoparticles Technology Market Revenue, 2013 – 2023 (US$ Mn)
FIGURE 16 Global Liposomes Technology Market Revenue, 2013 – 2023 (US$ Mn)
FIGURE 17 Global Micelles Technology Market Revenue, 2013 – 2023 (US$ Mn)
FIGURE 18 Global Nanotubes Technology Market Revenue, 2013 – 2023 (US$ Mn)
FIGURE 19 Global Other Nanotechnology Drug Delivery Platforms Technology Market Revenue, 2013 – 2023 (US$ Mn)
FIGURE 20 Global Neurology Application Market Revenue, 2013 – 2023 (US$ Mn)
FIGURE 21 Global Oncology Application Market Revenue, 2013 – 2023 (US$ Mn)
FIGURE 22 Global Cardiovascular/Physiology Application Market Revenue, 2013 – 2023 (US$ Mn)
FIGURE 23 Global Anti-inflammatory/Immunology Application Market Revenue, 2013 – 2023 (US$ Mn)
FIGURE 24 Global Anti-infective Application Revenue, 2013 – 2023 (US$ Mn)
FIGURE 25 Global Others Application Market Revenue, 2013 – 2023 (US$ Mn)
FIGURE 26 U.S. Nanotechnology Drug Delivery Market Revenue, 2013 – 2023 (US$ Mn)
FIGURE 27 Canada Nanotechnology Drug Delivery Market Revenue, 2013 – 2023 (US$ Mn)
FIGURE 28 U.K. Nanotechnology Drug Delivery Market Revenue, 2013 – 2023 (US$ Mn)
FIGURE 29 Germany Nanotechnology Drug Delivery Market Revenue, 2013 – 2023 (US$ Mn)
FIGURE 30 Rest of Europe Nanotechnology Drug Delivery Market Revenue, 2013 – 2023 (US$ Mn)
FIGURE 31 China Nanotechnology Drug Delivery Market Revenue, 2013 – 2023 (US$ Mn)
FIGURE 32 Japan Nanotechnology Drug Delivery Market Revenue, 2013 – 2023 (US$ Mn)
FIGURE 33 Rest of Asia Pacific Nanotechnology Drug Delivery Market Revenue, 2013 – 2023 (US$ Mn)
FIGURE 34 Brazil Nanotechnology Drug Delivery Market Revenue, 2013 – 2023 (US$ Mn)
FIGURE 35 Mexico Nanotechnology Drug Delivery Market Revenue, 2013 – 2023 (US$ Mn)
FIGURE 36 Rest of World Nanotechnology Drug Delivery Market Revenue, 2013 – 2023 (US$ Mn)
FIGURE 37 AbbVie, Inc.: Financial Overview, 2012 – 2014 (US$ Mn)
FIGURE 38 Amgen, Inc.: Financial Overview, 2012 – 2014 (US$ Mn)
FIGURE 39 Celgene Corporation: Financial Overview, 2012 – 2014 (US$ Mn)
FIGURE 40 Johnson & Johnson: Financial Overview, 2012 – 2014 (US$ Mn)
FIGURE 41 Merck & Co., Inc.: Financial Overview, 2012 – 2014 (US$ Mn)
FIGURE 42 Novartis International AG: Financial Overview, 2012 – 2014 (US$ Mn)
FIGURE 43 Perrigo Company plc: Financial Overview, 2012 – 2014 (US$ Mn)
FIGURE 44 Pfizer, Inc.: Financial Overview, 2012 – 2014 (US$ Mn)
FIGURE 45 Teva Pharmaceuticals Industries, Ltd.: Financial Overview, 2012 – 2014 (US$ Mn)

.